Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Probstfield

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
BMC Health Services Research|July 9, 2016
Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trialJeff Whittle, José-Miguel Yamal, Jeffrey D Williamson, et al.
Resuscitation|February 3, 2023
Scoping review of echocardiographic parameters associated with diagnosis and prognosis after resuscitated sudden cardiac arrestLinda Liu, Aris Karatasakis, Peter J Kudenchuk, et al.
Archives of Internal Medicine|June 11, 2008
Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosisDavid S Owens, Ronit Katz, Eric Johnson, et al.
Journal of the National Medical Association|August 22, 2018
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHATL Julian Haywood, Barry R Davis, Linda B Piller, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul Muntner, Barry R Davis, William C Cushman, et al.
Chest|January 6, 2025
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled TrialPeter J Leary, Samuel G Rayner, Kelley R H Branch, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Clinical Trials (London, England)|February 17, 2010
Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention TrialElise D Cook, Kathryn B Arnold, John A Hermos, et al.
American Heart Journal|April 27, 2020
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular diseaseWilliam E Boden, Michael G Miller, Ruth McBride, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
BMC Health Services Research|July 9, 2016
Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trialJeff Whittle, José-Miguel Yamal, Jeffrey D Williamson, et al.
Resuscitation|February 3, 2023
Scoping review of echocardiographic parameters associated with diagnosis and prognosis after resuscitated sudden cardiac arrestLinda Liu, Aris Karatasakis, Peter J Kudenchuk, et al.
Archives of Internal Medicine|June 11, 2008
Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosisDavid S Owens, Ronit Katz, Eric Johnson, et al.
Journal of the National Medical Association|August 22, 2018
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHATL Julian Haywood, Barry R Davis, Linda B Piller, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul Muntner, Barry R Davis, William C Cushman, et al.
Chest|January 6, 2025
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled TrialPeter J Leary, Samuel G Rayner, Kelley R H Branch, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Clinical Trials (London, England)|February 17, 2010
Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention TrialElise D Cook, Kathryn B Arnold, John A Hermos, et al.
American Heart Journal|April 27, 2020
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular diseaseWilliam E Boden, Michael G Miller, Ruth McBride, et al.
Pageof 9